Company Profile

Ropamedics is pursuing a non-invasive device to objectively measure acute pain. This pain measurement sensor will monitor patients pain continuously and in real-time thus replacing or complementing the subjective pain measurement and scoring that is practiced today. Improved pain monitoring could reduce length of stay (LOS) and decrease complications associated with over medication. A decrease in LOS of just 0.25 days could save over $5 billion/year. In addition, inefficient pain management is recognized as one of the major reasons patients become addicted to opiates. Opioid abuse in the US costs over $55.7 billion. An estimated market/revenue opportunity for this device is $450 million with limited adoption.